The secrecy that hampers PBAC decisions

The Decoding Nexavant: The Access & Evaluation Tug-of-War panel at NEXT 26 raised the veil on the challenges pharmas face in reaching an agreement to fund their drug, being that nobody really knows what price the other party is suggesting.